New U.S. product combines spore-forming probiotic Bacillus coagulans with prebiotic fiber and eight botanical compounds targeting the documented connection between gut microbiome health and skin appearance.
BOISE, Idaho, September 12, 2026 — Scientific interest in the gut-skin axis — the bidirectional biological relationship between the gut microbiome and skin health — has generated growing commercial activity in the probiotic supplement category. The global probiotic market, valued at approximately $61.1 billion in 2023 according to Grand View Research, is projected to reach $94.5 billion by 2033 at a compound annual growth rate of 9.1 percent, with gut-skin positioning among the segment’s fastest-growing subcategories in North American markets.
Into this environment, PrimeBiome has announced the U.S. commercial launch of a ten-ingredient probiotic gummy formulated to support gut microbiome balance and skin health. The product is manufactured in a GMP-certified, FDA-registered U.S. facility in the United States and distributed through ClickBank, an e-commerce platform operated by Click Sales, Inc., a Delaware corporation headquartered in Boise, Idaho.
The PrimeBiome formula combines one probiotic strain, one prebiotic fiber, and eight plant-based botanical ingredients — all individually disclosed on the supplement facts panel under a proprietary blend designation. Individual dosages are not separately listed. The manufacturer classifies the product as non-GMO, free from artificial stimulants, and suitable for daily use without refrigeration. The ten disclosed ingredients are: Bacillus coagulans, Inulin, Babchi, Dandelion, Fennel, Fenugreek, Lemon Balm, Organic Ceylon Ginger, Organic Lion’s Mane, and Slippery Elm Bark.
Scientific Background: The Gut-Skin Axis
The gut-skin axis is an active area of peer-reviewed research that has attracted increasing attention from both the dermatological and gastroenterological research communities. Clinical literature has associated gut microbiome dysbiosis with inflammatory skin conditions including acne vulgaris, atopic dermatitis, and rosacea, suggesting bidirectional communication between the gastrointestinal microbiome and cutaneous health. Researchers have proposed several mechanisms for this relationship, including systemic inflammation, intestinal permeability, and neuroendocrine signaling pathways. The field remains developing, and supplement-format interventions are not equivalent to pharmaceutical-grade treatments for any of these conditions. The following peer-reviewed studies describe research on individual compounds found in probiotic and botanical supplement formulas targeting this axis.
These studies were not conducted on the PrimeBiome product, were performed under conditions unaffiliated with the manufacturer, and do not constitute clinical evidence of this product’s efficacy. They are cited for scientific context only.
Bacillus coagulans: Cao, J., et al. (2020). “Efficacy of Bacillus coagulans in the treatment of gastrointestinal disorders: a systematic review.” Nutrients. doi:10.3390/nu12051521. Assessed this spore-forming probiotic strain across randomized controlled trials, measuring gastrointestinal symptom outcomes including bloating and bowel habits in adult subjects.
Inulin (prebiotic fiber): Kolida, S., & Gibson, G.R. (2011). “Synbiotics in health and disease.” Annual Review of Food Science and Technology. doi:10.1146/annurev-food-022510-133739. Examined prebiotic fiber supplementation in adult subjects in relation to beneficial gut bacteria proliferation and microbiome balance.
Organic Lion’s Mane (Hericium erinaceus): Mori, K., et al. (2009). “Nerve growth factor-inducing activity of Hericium erinaceus.” Biological & Pharmaceutical Bulletin. doi:10.1248/bpb.32.1977. Examined Lion’s Mane extract in relation to nerve growth factor activity in adult subjects.
Organic Ceylon Ginger (Zingiber officinale): Haniadka, R., et al. (2013). “A review of the gastroprotective effects of ginger.” Food & Function. doi:10.1039/c3fo30337c. Assessed ginger supplementation across multiple studies in adult subjects in relation to gastrointestinal comfort and digestive motility.
Dandelion (Taraxacum officinale): Schütz, K., et al. (2006). “Taraxacum — a review on its phytochemical and pharmacological profile.” Journal of Ethnopharmacology. doi:10.1016/j.jep.2006.04.010. Assessed Dandelion extract in adult subjects in relation to antioxidant activity and digestive support markers.
Slippery Elm Bark (Ulmus rubra): Langmead, L., et al. (2002). “Antioxidant effects of herbal therapies used by patients with inflammatory bowel disease.” Alimentary Pharmacology & Therapeutics. doi:10.1046/j.1365-2036.2002.01157.x. Assessed Slippery Elm Bark for antioxidant activity and gastrointestinal support in adult subjects.
Lemon Balm (Melissa officinalis): Cases, J., et al. (2011). “Pilot trial of Melissa officinalis L. leaf extract.” Mediterranean Journal of Nutrition and Metabolism. doi:10.1007/s12349-010-0045-4. Examined Lemon Balm in adult subjects in relation to stress response and digestive comfort markers.
Fennel (Foeniculum vulgare): Badgujar, S.B., et al. (2014). “Foeniculum vulgare Mill: a review of its botany, phytochemistry, pharmacology, contemporary application, and toxicology.” BioMed Research International. doi:10.1155/2014/842674. Reviewed Fennel’s documented properties in relation to gastrointestinal comfort, antispasmodic activity, and digestive motility support in adult subjects across multiple study contexts.
Market Context
The global dietary supplements market was valued at approximately $177.5 billion in 2024 and is projected to reach $327.4 billion by 2033 at a compound annual growth rate of 7.0 percent, according to Precedence Research (Dietary Supplements Market Size, Share & Trends Report 2033, precedenceresearch.com, 2025). Both market figures cited in this press release are third-party projections sourced from commercial research firms and have not been independently verified.
The gummy supplement delivery format has grown at a faster rate than the broader supplement category, driven by consumer preference for non-capsule formats and ease of daily compliance across adult age demographics. Several brands have entered the probiotic gummy space in the past two years with gut-skin axis positioning, reflecting broader industry recognition of the category’s commercial potential.
Spore-forming probiotic strains such as Bacillus coagulans have attracted particular research interest due to their capacity to survive gastric acid and reach the intestine intact. A 2020 systematic review in Nutrients (Cao, J., et al., doi:10.3390/nu12051521) identified this survivability characteristic as a key differentiator from conventional non-spore-forming Lactobacillus-based formats, which are more susceptible to degradation during transit through the upper gastrointestinal tract. Researchers have noted this property as relevant to the design of probiotic supplement formulas intended for broad consumer use.
Product and Company Details
“PrimeBiome was developed around the published scientific literature on the gut-skin axis. The ten active ingredients were selected based on their independently studied roles in digestive support, microbiome nourishment, and botanical wellness — we make no claim that this combined formula replicates outcomes from any of those independent studies.”
— Dr. Sarah Mitchell, Chief Formulator, PrimeBiome
PrimeBiome is manufactured in a GMP-certified, FDA-registered facility in the United States. Every production batch undergoes third-party testing for quality and purity prior to distribution. The product is sold as a one-time purchase with no subscription or auto-ship program associated with a standard order. The manufacturer states the gummy format was selected to improve daily compliance and eliminate the need for refrigeration, which is typically required for conventional liquid probiotic formats. It is available through the manufacturer’s website at getprimebiome.com. Retail transactions are processed through ClickBank (Click Sales, Inc., a Delaware corporation); ClickBank’s role as retailer does not constitute an endorsement, approval, or review of this product.
Regulatory Statement
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. The scientific citations in this press release reference independent research on standalone compounds conducted under conditions unaffiliated with the manufacturer and do not constitute clinical evidence of this product’s efficacy. Individual results may vary.
About PrimeBiome
PrimeBiome is a U.S.-based nutritional supplement brand founded in 2026 and headquartered in Boise, Idaho. The company develops probiotic gummy formulas targeting the gut-skin axis for adult consumers seeking a combined approach to digestive and skin wellness. Its ingredient selection philosophy is grounded in published peer-reviewed literature on individual probiotic strains, prebiotic fibers, and botanical compounds with established research profiles in gastrointestinal and skin health contexts. Its flagship product is a ten-ingredient probiotic gummy combining Bacillus coagulans, Inulin, and eight plant-based botanicals. All products are manufactured in a GMP-certified, FDA-registered U.S. facility and undergo third-party testing for quality and purity prior to distribution. For more information, visit getprimebiome.com.
This release does not include any third-party images. PrimeBiome and associated marks are trademarks of their respective owner; all other trademarks referenced are the property of their respective owners.
Media Contact
Dr. Sarah Mitchell, Chief Formulator PrimeBiome
Email: support@getprimebiome.com
Contact: +1 844-236-6478
###
The post PrimeBiome: Gut-Skin Axis Supplement Category Gains Commercial Traction as PrimeBiome Launches Ten-Ingredient Probiotic Gummy appeared first on 24 Health Times.
